CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 7 filers reported holding CRISPR THERAPEUTICS AG in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $49,763 | -22.8% | 1,096,354 | -4.5% | 0.08% | -18.3% |
| Q2 2023 | $64,445 | +23.2% | 1,147,929 | -0.8% | 0.10% | +14.3% |
| Q1 2023 | $52,323 | +8.3% | 1,156,810 | -2.7% | 0.09% | -6.2% |
| Q4 2022 | $48,305 | -99.9% | 1,188,321 | -4.6% | 0.10% | -41.2% |
| Q3 2022 | $81,374,000 | -4.1% | 1,245,199 | -10.8% | 0.16% | +5.1% |
| Q2 2022 | $84,850,000 | +4.7% | 1,396,258 | +8.2% | 0.16% | +45.4% |
| Q1 2022 | $81,030,000 | -18.8% | 1,290,905 | -1.9% | 0.11% | -10.7% |
| Q4 2021 | $99,736,000 | -3.8% | 1,316,123 | +42.1% | 0.12% | -4.7% |
| Q3 2021 | $103,638,000 | -29.5% | 925,914 | +1.9% | 0.13% | -28.7% |
| Q2 2021 | $147,101,000 | – | 908,652 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 3,608,874 | $160,053,562,000 | 54.44% |
| Abingworth LLP | 1,237,202 | $54,858,000 | 32.62% |
| NEA Management Company, LLC | 2,090,678 | $92,722,000 | 4.00% |
| New Leaf Venture Partners, L.L.C. | 444,708 | $19,723,000 | 3.59% |
| EcoR1 Capital, LLC | 500,000 | $22,175,000 | 2.00% |
| ARK Investment Management | 1,453,590 | $64,467,000 | 1.95% |
| CLOUGH CAPITAL PARTNERS L P | 337,731 | $14,978,000 | 1.41% |
| Casdin Capital, LLC | 220,000 | $9,757,000 | 1.19% |
| Valiant Capital Management, L.P. | 271,700 | $12,050,000 | 1.07% |
| Monashee Investment Management LLC | 110,000 | $4,879,000 | 1.03% |